Evidence for the Extrapulmonary Localization of Inhaled Nitric Oxide

Heart Disease

Volumn 5, Issue 6, 2003, Pages 372-377

  Lecour, Sandrine ^a   Clermont, Gaëlle ^a   Du Toit, Eugène ^b   Gilson, Laurent ^c   Maupoil, Véronique ^a   Lowe, Steven ^b   Dupuis, Patrick ^c   Girard, Claude ^c   Rochette, Luc ^a,d  

^a LPPCE   (France)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c HÔPITAL DU BOCAGE   (France)

^d LPPCE   (France)

Author keywords

Electron spin resonance; Extrapulmonary localization; Nitric oxide

Indexed keywords

CYCLIC GMP; N METHYLGLUCAMINE N CARBODITHIOIC ACID; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CARDIOPULMONARY INSUFFICIENCY; CONTROLLED STUDY; DOSE LIVER FUNCTION RELATION; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG SELECTIVITY; DRUG TISSUE LEVEL; ELECTRON SPIN RESONANCE; HEART; HEART DISEASE; LIVER; LUNG; LUNG VASODILATATION; LUNG VENTILATION PERFUSION MISMATCHING; LUNG VENTILATION PERFUSION RATIO; MALE; NONHUMAN; PULMONARY HYPERTENSION; RAT; SPIN TRAPPING; VASODILATATION;

ADMINISTRATION, INHALATION; ANIMALS; AORTA; BIOLOGICAL MARKERS; BLOOD PRESSURE; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; LUNG; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; NITRATES; NITRIC OXIDE; NITRITES; RATS; RATS, WISTAR; SORBITOL; SPIN LABELS; THIOCARBAMATES; TIME FACTORS;

EID: 0347504946     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hdx.0000098613.53486.08     Document Type: Article

References (32)

1. Kinsella JP, Neish SR, Shaffer E, et al. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:819-820.
2. Roberts JD, Polaner DM, Lang P, et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:818-819.
3. Girard C, Lehot JJ, Pannetier JC, et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology. 1992;77:880-883.
4. Girard C, Durand PG, Vedrinne C, et al. Case 4-1993. Inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiothorac Vasc Anesth. 1993;7:481-485.
5. Frostell C, Fratacci MD, Wain JC, et al. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991;83:2038-2047.
6. Frostell CG, Blomqvist H, Hedenstierna G, et al. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993;78:427-435.
7. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991;338:1173-1174.
8. Kermarrec N, Zunic P, Beloucif S, et al. Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5′-monophosphate. Am J Respir Crit Care Med. 1998;158:833-839.
9. Wessel DL, Adatia I, Giglia TM, et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993;88:2128-2138.
10. Quezado ZM, Natanson C, Karzai W, et al. Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis. J Appl Physiol. 1998;84:107-115.
11. Keaney JF Jr., Simon DI, Stamler JS, et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest. 1993;91:1582-1589.
12. Kubes P, Payne D, Grisham M, et al. Inhaled NO impacts vascular but not extra-vascular compartments in postischemic peripheral organs. Am J Physiol. 1999;277:46:H676-H682.
13. Neviere R, Mordon S, Marechal X, et al. Inhaled nitric oxide modulates leukocyte kinetics in the mesenteric venules of endotoxemic rats. Crit Care Med. 2000;28:1072-1076.
14. Lecour S, Maupoil V, Siri O, et al. Electron spin resonance detection of nitric oxide generation in major organs from LPS-treated rats. J Cardiovasc Pharmacol. 1999;33:78-85.
15. Lecour S, Maupoil V, Zeller M, et al. Levels of nitric oxide in the heart after experimental myocardial ischemia. J Cardiovasc Pharmacol. 2001;37:55-63.
16. Lecour S, Chevet D, Maupoil V, et al. Intrarenal detection of nitric oxide using electron spin resonance spectroscopy in hypertensive lipopolysaccharide-treated rats. J Cardiovasc Pharmacol. 2002;40:9-17.
17. Shinobu LA, Jones SG, Jones MM. Sodium N-methyl-D-glucamine dithiocarbamate and cadmium intoxication. Acta Pharmacol Toxicol (Copenh). 1984;54:189-194.
18. Clermont G, Vergely C, Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology. 2002;96:80-87.
19. du Toit EF, McCarthy J, Miyashiro J, et al. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts. Br J Pharmacol. 1998;123:1159-1167.
20. Jacob TD, Nakayama DK, Seki I, et al. Hemodynamic effects and metabolic fate of inhaled nitric oxide in hypoxic piglets. J Appl Physiol. 1994;76:1794-801.
21. Takahashi Y, Kobayashi H, Tanaka N, et al. Nitrosyl hemoglobin in blood of normoxic and hypoxic sheep during nitric oxide inhalation. Am J Physiol. 1998;274:H349-H357.
22. Brady TC, Crapo JD, Mercer RR. Nitric oxide inhalation transiently elevates pulmonary levels of cGMP, iNOS mRNA, and TNF-alpha. Am J Physiol. 1998;275:L509-L515.
23. Komarov AM, Lai CS. Detection of nitric oxide production in mice by spin-trapping electron paramagnetic resonance spectroscopy. Biochim Biophys Acta. 1995;1272:29-36.
24. Yoshida K, Kasama K. Biotransformation of nitric oxide. Environ Health Perspect. 1987;73:201-205.
25. Troncy E, Francoeur M, Salazkin I, et al. Extra-pulmonary effects of inhaled nitric oxide in swine with and without phenylephrine. Br J Anaesth. 1997;79:631-640.
26. Wraight WM, Young JD. Renal effects of inhaled nitric oxide in humans. Br J Anaesth. 2001;86:267-269.
27. Hayward CS, Kelly RP, Macdonald PS. Inhaled nitric oxide in cardiology practice. Cardiovasc Res. 1999;43:628-638.
28. Mulsch A, Mordvintcev P, Bassenge E, et al. In vivo spin trapping of glyceryl trinitrate-derived nitric oxide in rabbit blood vessels and organs. Circulation. 1995;92:1876-1882.
29. Scharfstein J, Keaney J, Slivkka A, et al. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest. 1994;94:1432-1439.
30. Liu Z, Rudd MA, Freedman JE, et al. S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther. 1998;284:526-34.
31. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta. 1999;1411:279-289.
32. Moya MP, Gow AJ, Califf RM, et al. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet. 2002;360:141-143.